[ÀÌÈñÁ¤] R&D¿¬±¸¿ø, ÇØ¿Ü¹Ú»çÇÐÀ§¼ÒÁöÀÚ Post - doc ¹× »ê¾÷ü °æ·ÂÀÚ ¸ðÁý

Date 11/04/2008   Hits 1315

1. ÀÇ·Ú»ç: ±¹³» Major Á¦¾à»ç

2. ¸ðÁý ³»¿ë : R&D¿¬±¸¿ø, ÇØ¿Ü¹Ú»çÇÐÀ§¼ÒÁöÀÚ Post - doc ¹× »ê¾÷ü °æ·ÂÀÚ ¸ðÁý

¢Ã Position : R&D ¿¬±¸¼Ò ¼Ò¼Ó - Á¤±ÔÁ÷ - 00¸í ¸ðÁý

- ¹Ú»çÇÐÀ§¼ÒÁöÀÚ Çʼö
- ³²³à¹«°ü
- ¸ðÁý ºÎ¹® ¹Ú»çÇÐÀ§ ¼ÒÁöÀÚ·Î Post-doc ¹× °ü·Ã »ê¾÷ü °æ·ÂÀÚ ¿ì´ë

¢Ã ¸ðÁý ºÎ¹® ¹× ÀÀ½Ã ÀÚ°Ý

1)¸é¿ªÄ¡·áÁ¦¿Í ¹é½Å °³¹ß Immunotherapy and vaccines:
¼¼Æ÷¸é¿ªÇÐ Cellular immunology /
ºÐÀÚ¹ÙÀÌ·¯½ºÇÐ Molecular virology
- Á÷ ¹«: DNA Ä¡·á¿ë¹é½Å °³¹ß, ¹é½Å adjuvant °ü·Ã ¿¬±¸
- Àü °ø: ¼¼Æ÷»ý¹°ÇÐ,¸é¿ªÇÐ, »ýÈ­ÇÐ, ¹ÙÀÌ·¯½ºÇÐ Àü°ø ¹Ú»ç
ÇÐÀ§ ¼ÒÁöÀÚ

2)Ç×¾ÏÁ¦ °³¹ß Anti-cancer drugs:
¾Ï»ý¹°ÇÐ Cancer biology /
Ç×Ç÷°ü½Å»ý Anti-angiogenesis
- Á÷ ¹«: Cancer °ü·Ã Ä¡·áÁ¦ °³¹ß, ÀÛ¿ë±âÀü ¹× target ¹ß
±¼ ¿¬±¸
- Àü °ø: Oncology, Cancer biology °ü·Ã Àü°ø ¹Ú»çÇÐÀ§ ¼Ò
ÁöÀÚ

3) ¼¼Æ÷Ä¡·áÁ¦ °³¹ß Cell therapy :
Áٱ⼼Æ÷ÀÇ ÀÚ°¡Àç»ý,ºÐÈ­ ¹× ¼¼Æ÷»ý¹°ÇÐ,¸é¿ªÇÐ -
Self-renewal,differentiation and plasticity of stem cells
- Á÷ ¹«: Áٱ⼼Æ÷, ¸é¿ª¼¼Æ÷ Ä¡·áÁ¦ °³¹ß ¹× °ü·Ã ¿¬±¸
- Àü °ø: ¼¼Æ÷»ý¹°ÇÐ, ¹ß»ý»ý¹°ÇÐ ¹× °ü·Ã Àü°ø ¹Ú»çÇÐÀ§ ¼Ò
ÁöÀÚ

4) ¾à¹°Àü´ÞÁ¦ °³¹ß Drug delivery :
À¯ÀüÀÚ,´Ü¹éÁú ¹× ÀÛÀº Å©±âÀÇ ºÐÀÚ Àü´Þ -
Gene,protein,and small molecule delivery
- Á÷ ¹« : ¾à¹°,¾àÁ¦ °³¹ß¿¡ Áß¿äÇÑ ºÐ¾ß Áß ÇϳªÀΠȯÀÚ Åõ
¿©¿¡ °ü·ÃµÈ Àü´Þ ¹æ½Ä ºÎºÐ¿¡ ´ëÇÑ ¿¬±¸
- Àü °ø : ºÐÀÚ»ý¹°ÇÐ,biotechnology ¹× nanotechnology °ü
·Ã Àü°ø ¹Ú»çÇÐÀ§ ¼ÒÁöÀÚ

5) À¯ÀüÀÚ ¹ßÇö¿¡ ´ëÇÑ °³¹ß Gene expression :
¼÷ÁÖ¼¼Æ÷Á¶ÀÛ Host cell engineering /
Ç×üÁ¶ÀÛ Antibody engineering -
- Á÷ ¹« : À¯ÀüÀÚ ¹ßÇö¿¡ °ü·ÃµÈ ¿¬±¸
- Àü °ø : ºÐÀÚ»ý¹°ÇÐ,¸é¿ªÇÐ,¼¼Æ÷»ý¹°ÇÐ °ü·Ã Àü°ø ¹Ú»ç ÇÐ
À§ ¼ÒÁöÀÚ

¢Ã ¿¬ºÀ¼öÁØ ¹× º¹¸®ÈÄ»ý : Çö, ¿¬ºÀÀÌ»óÀ¸·Î ÃßÈÄ ÇùÀÇ °¡´É ¿Ü °æ·Â¿¡ µû¶ó Á÷±Þ ÇùÀÇ /±Ù¹«Á¦µµ : ÁÖ 5ÀÏÁ¦ / º¸Çè : ±¹¹Î¿¬±Ý, ÀǷẸÇè, »êÀ纸Çè, °í¿ëº¸Çè

¢Ã ±Ù¹«Áö : °æ±âµµ

¢Ã ÁøÇàÀýÂ÷ : 1Â÷ ¼­·ù ÀüÇü- 2Â÷ ¸éÁ¢(À¯¼±Æ÷ÇÔ)ÀüÇü

¢Ã Á¦Ãâ¼­·ù: ±¹/¿µ¹® À̷¼­(»çÁøÇʼö)¿Í °æ·Â ±â¼ú¼­ ¶Ç´Â Àڱ⠼Ұ³¼­(¿¬±¸°æ·Â ¼Ò°³, bibliography, 3 references
Æ÷ÇÔ)

¢Ã ´ã´çÀÚ: ÀÌ Èñ Á¤
02-567-7407,7408
yskim@jhhr.co.kr